FindTrial
Sign In

Prescribing patterns for elderly Parkinson's disease in Japan using claims data

Prescribing patterns for elderly Parkinson's disease in Japan using claims data - Prescribing patterns for elderly Parkinson's disease in Japan

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000046823
Enrollment
Unknown
Registered
2022-02-03
Start date
2022-02-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

None listed

Sponsors

Takeda Pharmaceutical Company Limited
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who have been identified Parkinson's disease (G20) for more than 6 months and have been prescribed at least one anti-PD drug for more than 6 months, at least twice.

Exclusion criteria

Exclusion criteria: Patients under 30 years of age and patients with Parkinson's disease syndrome

Design outcomes

Primary

MeasureTime frame
Prescribing patterns of anti-Parkinson's diseases drugs—

Countries

Japan

Contacts

Public ContactMasaki Arai

Takeda Pharmaceutical Company Limited Japan Medical Office

arai.masaki@takeda.com03-3278-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026